These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 21559518)

  • 1. Cyclosporin A associated helicase-like protein facilitates the association of hepatitis C virus RNA polymerase with its cellular cyclophilin B.
    Morohashi K; Sahara H; Watashi K; Iwabata K; Sunoki T; Kuramochi K; Takakusagi K; Miyashita H; Sato N; Tanabe A; Shimotohno K; Kobayashi S; Sakaguchi K; Sugawara F
    PLoS One; 2011 Apr; 6(4):e18285. PubMed ID: 21559518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different mechanisms of hepatitis C virus RNA polymerase activation by cyclophilin A and B in vitro.
    Weng L; Tian X; Gao Y; Watashi K; Shimotohno K; Wakita T; Kohara M; Toyoda T
    Biochim Biophys Acta; 2012 Dec; 1820(12):1886-92. PubMed ID: 22954804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclophilin A is an essential cofactor for hepatitis C virus infection and the principal mediator of cyclosporine resistance in vitro.
    Yang F; Robotham JM; Nelson HB; Irsigler A; Kenworthy R; Tang H
    J Virol; 2008 Jun; 82(11):5269-78. PubMed ID: 18385230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical genetics approach to hepatitis C virus replication: cyclophilin as a target for anti-hepatitis C virus strategy.
    Watashi K; Shimotohno K
    Rev Med Virol; 2007; 17(4):245-52. PubMed ID: 17299803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclophilin B is a functional regulator of hepatitis C virus RNA polymerase.
    Watashi K; Ishii N; Hijikata M; Inoue D; Murata T; Miyanari Y; Shimotohno K
    Mol Cell; 2005 Jul; 19(1):111-22. PubMed ID: 15989969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclosporine inhibits a direct interaction between cyclophilins and hepatitis C NS5A.
    Fernandes F; Ansari IU; Striker R
    PLoS One; 2010 Mar; 5(3):e9815. PubMed ID: 20352119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of cellular and viral factors related to anti-hepatitis C virus activity of cyclophilin inhibitor.
    Goto K; Watashi K; Inoue D; Hijikata M; Shimotohno K
    Cancer Sci; 2009 Oct; 100(10):1943-50. PubMed ID: 19659609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclophilin B stimulates RNA synthesis by the HCV RNA dependent RNA polymerase.
    Heck JA; Meng X; Frick DN
    Biochem Pharmacol; 2009 Apr; 77(7):1173-80. PubMed ID: 19174155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of hepatitis C virus subgenomic replicon resistance to cyclosporine in vitro.
    Robida JM; Nelson HB; Liu Z; Tang H
    J Virol; 2007 Jun; 81(11):5829-40. PubMed ID: 17376913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of hepatitis C virus replication by cyclosporin a is mediated by blockade of cyclophilins.
    Nakagawa M; Sakamoto N; Tanabe Y; Koyama T; Itsui Y; Takeda Y; Chen CH; Kakinuma S; Oooka S; Maekawa S; Enomoto N; Watanabe M
    Gastroenterology; 2005 Sep; 129(3):1031-41. PubMed ID: 16143140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diverse effects of cyclosporine on hepatitis C virus strain replication.
    Ishii N; Watashi K; Hishiki T; Goto K; Inoue D; Hijikata M; Wakita T; Kato N; Shimotohno K
    J Virol; 2006 May; 80(9):4510-20. PubMed ID: 16611911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treating hepatitis C: can you teach old dogs new tricks?
    Rice CM; You S
    Hepatology; 2005 Dec; 42(6):1455-8. PubMed ID: 16317665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional machinery of TNF-α-inducible YTH domain containing 2 (YTHDC2) gene.
    Tanabe A; Konno J; Tanikawa K; Sahara H
    Gene; 2014 Feb; 535(1):24-32. PubMed ID: 24269672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a cyclophilin inhibitor in hepatitis C virus-infected chimeric mice in vivo.
    Inoue K; Umehara T; Ruegg UT; Yasui F; Watanabe T; Yasuda H; Dumont JM; Scalfaro P; Yoshiba M; Kohara M
    Hepatology; 2007 Apr; 45(4):921-8. PubMed ID: 17393519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A major determinant of cyclophilin dependence and cyclosporine susceptibility of hepatitis C virus identified by a genetic approach.
    Yang F; Robotham JM; Grise H; Frausto S; Madan V; Zayas M; Bartenschlager R; Robinson M; Greenstein AE; Nag A; Logan TM; Bienkiewicz E; Tang H
    PLoS Pathog; 2010 Sep; 6(9):e1001118. PubMed ID: 20886100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical role of cyclophilin A and its prolyl-peptidyl isomerase activity in the structure and function of the hepatitis C virus replication complex.
    Liu Z; Yang F; Robotham JM; Tang H
    J Virol; 2009 Jul; 83(13):6554-65. PubMed ID: 19386705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporin A inhibits hepatitis C virus replication and restores interferon-alpha expression in hepatocytes.
    Liu JP; Ye L; Wang X; Li JL; Ho WZ
    Transpl Infect Dis; 2011 Feb; 13(1):24-32. PubMed ID: 21040279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of AlphaLISA technology to detect interaction between hepatitis C virus-encoded NS5A and cyclophilin A.
    Waller H; Chatterji U; Gallay P; Parkinson T; Targett-Adams P
    J Virol Methods; 2010 May; 165(2):202-10. PubMed ID: 20132841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the anti-hepatitis C virus effects of cyclophilin inhibitors, cyclosporin A, and NIM811.
    Goto K; Watashi K; Murata T; Hishiki T; Hijikata M; Shimotohno K
    Biochem Biophys Res Commun; 2006 May; 343(3):879-84. PubMed ID: 16564500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HCV genotype 1b chimeric replicon with NS5B of JFH-1 exhibited resistance to cyclosporine A.
    Abe K; Ikeda M; Ariumi Y; Dansako H; Wakita T; Kato N
    Arch Virol; 2009; 154(10):1671-7. PubMed ID: 19779801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.